⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
globenewswire.com
GMAB
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
globenewswire.com
GMAB
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
globenewswire.com
GMAB
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S ®) in Combination with Bevacizumab in Advanced Ovarian Cancer
businesswire.com
GMAB
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
globenewswire.com
GMAB
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
globenewswire.com
GMAB
Major Shareholder Announcement
globenewswire.com
GMAB
Major Shareholder Announcement
globenewswire.com
GMAB
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
globenewswire.com
GMAB
Passing of Genmab A/S’ Annual General Meeting
globenewswire.com
GMAB